Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sorrento, NantWorks commit $20mm to new immunotherapies JV; commitments later enhanced

Executive Summary

Sorrento Therapeutics Inc. and NantWorks LLC founder Dr. Patrick Soon-Shiong have agreed to together invest $20mm in a new joint venture, to be named The Immunotherapy Antibody JV, which will operate as an independent entity.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Joint Venture
    • R+D and Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register